Women’s Comprehensive Cardiometabolic Master Panel
An extensive women’s cardiometabolic master panel combining advanced lipid particle testing, ApoA1/ApoB ratio, Lipoprotein (a), oxidized LDL, LP-PLA2, hs-CRP, cardiac biomarkers, thyroid antibodies, insulin resistance markers, kidney function, oxidative stress testing, and more. Designed to provide a comprehensive, multi-system evaluation of heart and metabolic health.
- $2,432.47
- $1,049
- Save: 56.88%
The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.
Adiponectin
Also known as: Microalbumin Random Urine with Creatinine
Creatinine, Random Urine
Microalbumin
Microalbumin/Creatinine
Apolipoprotein A1
Apolipoprotein B
Apolipoprotein B/A1 Ratio
Also known as: CBC, CBC includes Differential and Platelets, CBC/PLT w/DIFF, Complete Blood Count (includes Differential and Platelets)
NOTE: Ulta Lab Tests provides CBC test results from Quest Diagnostics as they are reported. Often, different biomarker results are made available at different time intervals. When reporting the results, Ulta Lab Tests denotes those biomarkers not yet reported as 'pending' for every biomarker the test might report. Only biomarkers Quest Diagnostics observes are incorporated and represented in the final CBC test results provided by Ulta Lab Tests.
Absolute Band Neutrophils (Only Reported If Detected)
Absolute Basophils
Absolute Blasts (Only Reported If Detected)
Absolute Eosinophils
Absolute Lymphocytes
Absolute Metamyelocytes (Only Reported If Detected)
Absolute Monocytes
Absolute Myelocytes (Only Reported If Detected)
Absolute Neutrophils
Absolute Nucleated Rbc (Only Reported If Detected)
Absolute Promyelocytes (Only Reported If Detected)
Band Neutrophils (Only Reported If Detected)
Basophils
Blasts (Only Reported If Detected)
Eosinophils
Hematocrit
Hemoglobin
Lymphocytes
MCH
MCHC
MCV
Metamyelocytes (Only Reported If Detected)
Monocytes
MPV
Myelocytes (Only Reported If Detected)
Neutrophils
Nucleated Rbc (Only Reported If Detected)
Platelet Count
Promyelocytes (Only Reported If Detected)
RDW
Reactive Lymphocytes (Only Reported If Detected)
Red Blood Cell Count
White Blood Cell Count
Also known as: Chem 12, Chemistry Panel, Chemistry Screen, CMP, Complete Metabolic Panel, Comprehensive Metabolic Panel CMP, SMA 12, SMA 20
Albumin
Albumin/Globulin Ratio
Alkaline Phosphatase
Alt
AST
Bilirubin, Total
Bun/Creatinine Ratio
Calcium
Carbon Dioxide
Chloride
Creatinine
Egfr African American
Egfr Non-Afr. American
GFR-AFRICAN AMERICAN
GFR-NON AFRICAN AMERICAN
Globulin
Glucose
Potassium
Protein, Total
Sodium
Urea Nitrogen (Bun)
CYSTATIN C
eGFR
CREATININE, URINE
F2-ISOPROSTANE
F2-ISOPROSTANE/CREAT
Ferritin
Also known as: Factor I, Fibrinogen, Fibrinogen Activity Clauss
Fibrinogen Activity,
GALECTIN 3
Also known as: Gamma Glutamyl Transferase GGT, Gamma-Glutamyl Transferase, Gamma-Glutamyl Transpeptidase, Gamma-GT, GGTP, GTP
Ggt
Also known as: A1c, Glycated Hemoglobin, Glycohemoglobin, Glycosylated Hemoglobin, HA1c, HbA1c, Hemoglobin A1c, Hemoglobin A1c HgbA1C, Hgb A1c
HEMOGLOBIN A1C
Also known as: Homocysteine, Homocysteine Cardiovascular
HOMOCYSTEINE,
Also known as: C-Reactive Protein, Cardio CRP, Cardio hs-CRP, CRP, High Sensitivity CRP, High-sensitivity C-reactive Protein, High-sensitivity CRP, Highly Sensitive CRP, hsCRP, Ultra-sensitive CRP
Hs Crp
Also known as: Insulin (fasting)
Insulin
Leptin
Also known as: Cholesterol, HDL,Fasting Lipids,Cholesterol, LDL, Fasting Lipids, Lipid Panel (fasting), Lipid Profile (fasting), Lipids
Chol/HDLC Ratio
Cholesterol, Total
HDL Cholesterol
LDL-Cholesterol
Non HDL Cholesterol
Triglycerides
Also known as: Lipoprotein A, Lp (a), Lp(a)
Lipoprotein (A)
HDL P
HDL SIZE
LARGE HDL P
LARGE VLDL P
LDL P
LDL SIZE
SMALL LDL P
VLDL SIZE
LP PLA2 ACTIVITY
Also known as: Anti-Myeloperoxidase, Churg-Strauss Syndrome, Crescentic Glomeruloephritis, MPO, Myeloperoxidase Antibody MPO
Myeloperoxidase Antibody
OxLDL
Also known as: BNP, N-terminal pro b-type natriuretic peptide, proBNP Nterminal
Probnp, N Terminal
Also known as: Reverse T3, Reverse Triiodothyronine, RT3, T3 Reverse RT3 LCMSMS, Triiodothyronine Reverse
T3 Reverse, LC/MS/MS
Also known as: Free T3, FT3, T3 Free
T3, Free
Also known as: Free T4, FT4, T4 Free
T4, Free
Thyroglobulin Antibodies
Thyroid Peroxidase
TROPONIN T, HIGH
Also known as: Thyroid Stimulating Hormone Test, Thyrotropin Test
TSH
Also known as: ,25-Hydroxyvitamin D2, 25-Hydroxycholecalciferol (25OHD3), 25-OH-D2,D3 Vitamin, D2 Vitamin,25-Hydroxyvitamin D3,25-OH-D3, QuestAssureD 25Hydroxyvitamin D D2 D3 LCMSMS, Vitamin D, Vitamin D, 25-Hydroxy, Vitamin D2, 25-hydroxy,25-Hydroxyergocalciferol (25OHD2),Vitamin D3, 25-hydroxy
Vitamin D, 25-Oh, Total
The Women’s Comprehensive Cardiometabolic Master Panel panel contains 30 tests with 102 biomarkers .
A Comprehensive, Multi-System Cardiometabolic and Cardiovascular Risk Assessment for Women
The Women’s Comprehensive Cardiometabolic Master Panel is an extensive, systems-based laboratory evaluation designed to assess cardiovascular risk, metabolic function, inflammatory burden, oxidative stress, endocrine balance, renal health, and cardiac biomarkers in women. This master-level panel integrates traditional lipid testing with advanced lipoprotein particle analysis, vascular inflammation markers, thyroid autoimmunity screening, metabolic hormones, kidney filtration markers, and cardiac stress indicators into one cohesive profile.
Cardiometabolic disease in women is multifactorial. Cholesterol levels alone do not fully capture cardiovascular risk. Lipoprotein particle number, genetic lipoprotein factors such as Lipoprotein (a), insulin resistance, chronic inflammation, oxidative damage, thyroid dysfunction, adipose signaling imbalance, renal stress, and subclinical cardiac strain all influence long-term outcomes. This panel was designed to evaluate these interconnected systems simultaneously.
Advanced lipid testing includes Apolipoprotein A1, Apolipoprotein B with ratio, Lipoprotein (a), Lipoprotein Fractionation by NMR, oxidized LDL, and LP-PLA2 activity. Inflammatory and vascular markers such as hs-CRP, Homocysteine, Fibrinogen Activity, Galectin-3, Myeloperoxidase (MPO) antibodies, and F2 Isoprostane/Creatinine Ratio provide insight into endothelial health and oxidative stress. Cardiac biomarkers including High-Sensitivity Troponin T and NT-proBNP add further context regarding myocardial strain.
Metabolic and endocrine contributors are evaluated through Hemoglobin A1c, Insulin, Leptin, Adiponectin, and a full thyroid panel (TSH, Free T4, Free T3, Reverse T3, Thyroid Peroxidase Antibodies, and Thyroglobulin Antibodies). Kidney and organ health markers, including Cystatin C with eGFR and urine Albumin/Creatinine Ratio, further expand the clinical picture.
Together, these biomarkers provide a master-level cardiometabolic evaluation designed specifically for women seeking a comprehensive, data-driven assessment.
When and Why Someone Would Order This Panel
Comprehensive Cardiovascular and Metabolic Risk Assessment
Women may consider the Women’s Comprehensive Cardiometabolic Master Panel when seeking an advanced and highly detailed evaluation of heart and metabolic health. Standard cholesterol testing provides important information, but it does not fully assess lipoprotein particle burden, inflammatory activity, oxidative stress, adipokine signaling, thyroid autoimmunity, renal function, or cardiac strain. This panel addresses those additional dimensions.
This panel may be appropriate for women who:
-
Have a family history of premature cardiovascular disease
-
Have previously elevated cholesterol or abnormal lipid particle results
-
Are monitoring cardiometabolic risk over time
-
Are experiencing metabolic changes during perimenopause or menopause
-
Have multiple cardiovascular or metabolic risk factors
-
Want a more comprehensive evaluation beyond standard screening
Evaluation of Inflammatory and Oxidative Pathways
Chronic low-grade inflammation and oxidative stress are central to atherosclerosis development. Markers such as hs-CRP, F2 Isoprostanes, MPO antibodies, LP-PLA2 activity, Homocysteine, and Galectin-3 provide insight into inflammatory signaling, endothelial dysfunction, plaque-related processes, and fibrotic remodeling.
Women seeking a deeper understanding of vascular inflammation or oxidative stress burden may benefit from this expanded assessment.
Hormonal, Thyroid, and Metabolic Considerations
Insulin resistance, altered adipokine signaling (Leptin and Adiponectin), and thyroid dysfunction can significantly influence lipid metabolism and cardiovascular risk. The inclusion of a full thyroid panel with autoimmune antibodies supports evaluation of both functional thyroid status and autoimmune thyroid processes.
Cardiac and Renal Health Monitoring
High-Sensitivity Troponin T and NT-proBNP provide insight into myocardial stress and cardiac wall strain. Kidney markers such as Cystatin C with eGFR and urine Albumin/Creatinine Ratio are included because renal health is closely tied to cardiovascular outcomes.
This panel may be used for preventive screening, comprehensive risk stratification, or longitudinal monitoring of cardiometabolic health.
What Does the Panel Measure?
Advanced Lipid and Lipoprotein Testing
-
Lipid Panel: Total cholesterol, LDL, HDL, and triglycerides
-
Apolipoprotein A1 and B with Ratio: Evaluates balance between protective and atherogenic lipoproteins
-
Lipoprotein (a): Genetically influenced cardiovascular risk marker
-
Lipoprotein Fractionation NMR: Measures LDL particle number and size
-
Oxidized LDL: Assesses oxidative modification of LDL particles
-
LP-PLA2 Activity: Marker associated with vascular inflammation
Inflammation and Oxidative Stress Markers
-
High-Sensitivity CRP (hs-CRP)
-
Homocysteine
-
Fibrinogen Activity
-
Galectin-3
-
F2 Isoprostane/Creatinine Ratio
-
Myeloperoxidase Antibody (MPO)
These biomarkers evaluate inflammatory signaling, endothelial injury, oxidative stress, and vascular remodeling.
Cardiac Biomarkers
-
High-Sensitivity Troponin T: Marker of myocardial cell injury
-
N-Terminal proBNP (NT-proBNP): Marker of cardiac wall stress
Metabolic and Endocrine Markers
-
Hemoglobin A1c and Insulin: Assess glucose regulation and insulin resistance
-
Leptin and Adiponectin: Adipose-derived hormones influencing metabolic signaling
-
TSH, Free T4, Free T3, Reverse T3: Comprehensive thyroid function
-
Thyroid Peroxidase and Thyroglobulin Antibodies: Markers associated with autoimmune thyroid conditions
Organ Function and Nutrient Markers
-
Comprehensive Metabolic Panel (CMP)
-
GGT
-
Cystatin C with eGFR
-
Albumin/Creatinine Ratio (Urine)
-
Complete Blood Count (CBC)
-
Vitamin D 25-Hydroxy
-
Ferritin
Together, these markers provide a broad, integrated cardiometabolic and systemic health profile.
How Patients and Healthcare Providers Use the Results
Refined Cardiovascular Risk Stratification
Advanced lipid particle analysis (ApoB, NMR LDL particle number), Lp(a), oxidized LDL, and LP-PLA2 help refine cardiovascular risk assessment beyond LDL cholesterol alone. Elevated particle burden or vascular inflammation markers may indicate increased atherosclerotic risk patterns.
Inflammation and Oxidative Stress Evaluation
Elevated hs-CRP, MPO antibodies, F2 Isoprostanes, Homocysteine, or Fibrinogen Activity may reflect increased inflammatory or oxidative stress activity. These findings help contextualize cardiovascular risk within a broader inflammatory framework.
Cardiac Stress Monitoring
High-Sensitivity Troponin T and NT-proBNP provide additional insight into myocardial strain and cardiac wall stress when interpreted alongside other findings.
Thyroid and Metabolic Interpretation
Thyroid dysfunction or autoimmune thyroid antibodies may influence lipid metabolism and cardiovascular markers. Insulin resistance patterns and adipokine imbalance may suggest metabolic syndrome or cardiometabolic dysregulation.
Kidney and Organ Health Context
Cystatin C, eGFR, and urine albumin levels support early detection of kidney-related cardiovascular risk. CMP and GGT provide liver and metabolic context.
This comprehensive panel supports evidence-based discussions and personalized health planning grounded in objective laboratory findings.
A Master-Level Cardiometabolic Evaluation for Women
The Women’s Comprehensive Cardiometabolic Master Panel offers an integrated, multidimensional assessment of cardiovascular and metabolic health. By combining advanced lipid particle testing, inflammatory and oxidative markers, cardiac biomarkers, thyroid autoimmunity screening, renal evaluation, and metabolic hormone analysis, this panel provides a master-level overview of the interconnected systems that influence long-term cardiometabolic wellness.
Cardiovascular risk in women is complex and multifactorial. This panel is designed to provide clarity through comprehensive biomarker evaluation, supporting informed conversations between patients and healthcare providers.
Through a broad, data-driven approach, this panel enables a deeper understanding of cardiometabolic health patterns and supports proactive, individualized monitoring strategies based on measurable laboratory insights.